NEW YORK, Jan. 5, 2018 /PRNewswire/ --
WallStEquities.com strives to bring the best free research to the investmentcommunity. Today we are offering reports on EVH, ATHN, HQY, and VEEV which can be accessed for free by signing up to www.wallstequities.com/registration. On Thursday, January 04, 2018, the NASDAQ Composite, the Dow
On Thursday, shares in Arlington, Virginia headquartered Evolent Health Inc. recorded a trading volume of 892,430 shares. The stock ended at $13.25, declining 1.12% from the last trading session. The Company's shares have gained 1.92% in the last month. The stock is trading above its 50-day moving average by 0.85%. Furthermore, shares of Evolent Health, which through its subsidiary, Evolent Health LLC, provides healthcare delivery and payment solutions in the US, have a Relative Strength Index (RSI) of 52.21. Get the full research report on EVH for free by clicking below at: www.wallstequities.com/registration/?symbol=EVH
Watertown, Massachusetts headquartered athenahealth Inc.'s stock finished yesterday's session 0.20% lower at $135.10. A total volume of 316,007 shares was traded. The Company's shares have gained 12.06% over the previous three months and 17.85% in the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 3.80% and 4.47%, respectively. Furthermore, shares of athenahealth, which together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems, have an RSI of 56.78.
On December 08th, 2017, research firm Deutsche Bank initiated a 'Hold' rating on the Company's stock, with a target price of $145 per share. Today's complimentary research report on ATHN is accessible at: www.wallstequities.com/registration/?symbol=ATHN
At the close of trading on Thursday, shares in Draper, Utah headquartered HealthEquity Inc. saw a rise of 1.57%, ending the day at $48.02. The stock recorded a trading volume of 396,819 shares. The Company's shares have advanced 17.64 % over the last twelve months. The stock is trading above its 200-day moving average by 1.45%. Moreover, shares of HealthEquity, which provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the US, have an RSI of 50.56.
On December 06th, 2017, research firm Chardan Capital Markets reiterated its 'Buy' rating on the Company's stock with an increase of the target price from $58 a share to $62 a share. Sign up for free on Wall St. Equities and claim the latest report on HQY at: www.wallstequities.com/registration/?symbol=HQY
Pleasanton, California headquartered Veeva Systems Inc.'s shares ended the day 1.10% higher at $56.90 with a total trading volume of 834,237 shares. The stock has gained 36.22% over the last twelve months. The Company's shares are trading below their 50-day moving average by 3.39%. Additionally, shares of Veeva Systems, which provides cloud-based software for the life sciences industry in North America, Europe, Asia/Pacific, and internationally, have an RSI of 48.91. See the free research coverage on VEEV at: www.wallstequities.com/registration/?symbol=VEEV
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/
For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: email@example.com Phone number: +21-32-044-483Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
View original content:http://www.prnewswire.com/news-releases/whats-happening-with-these-healthcare-information-services-stocks----evolent-health-athenahealth-healthequity-and-veeva-systems-300578097.html
SOURCE Wall St. Equities
Subscribe to our Free Newsletters!
Abortion pills are used in the first trimester to terminate pregnancy. Women should be aware of ...
Tea tree oil is an essential oil derived from the leaves of the Melaleuca alternifolia plant and ...
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...View All